We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

QIAGEN and Center for Molecular Medicine Collaborates for Molecular Diagnostic Markets for Breast Cancer

News   Feb 19, 2008

 
QIAGEN and Center for Molecular Medicine Collaborates for Molecular Diagnostic Markets for Breast Cancer
 
 
 

RELATED ARTICLES

Directing Self-propelled Protocells To Deliver Drugs

News

Synthetic protocells can be made to move toward and away from chemical signals, an important step for the development of new drug-delivery systems that could target specific locations in the body.

READ MORE

Genetic Alterations Caused by Cancer Therapies Are Identified

News

Scientists have determined the genetic alterations caused by the main cancer therapies, an important step towards understanding long-term side effects and treatment optimization.

READ MORE

Screening System Designed To Detect Drugs That Block Drivers of Cancer Cell Growth

News

A new screening system leverages redundancy in an important component of a cell – nucleotide metabolism – to help detect new drugs that specifically and potently block processes that are essential for cancer cell growth.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE